Company Directory - Bristol Myers Squibb
CCI Score
CCI Score: Bristol Myers Squibb
30.41
-0.02%
Latest Event
Senate Investigation Exposes Big Pharma Tax Dodging Involving Bristol Myers Squibb
A Senate investigation into aggressive tax avoidance practices in Big Pharma reveals that Bristol Myers Squibb, among other major pharmaceutical companies, has been implicated in schemes designed to minimize U.S. tax liabilities. These practices contribute to widening economic inequality and bolster corporate structures that indirectly support authoritarian policy-making.
Take Action
So what can you do? Support BMS by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
DISSENTER
Bristol Myers Squibb is currently rated as a Dissenter.
Latest Events
MAR272025A Senate investigation into aggressive tax avoidance practices in Big Pharma reveals that Bristol Myers Squibb, among other major pharmaceutical companies, has been implicated in schemes designed to minimize U.S. tax liabilities. These practices contribute to widening economic inequality and bolster corporate structures that indirectly support authoritarian policy-making.
- MAR012025
Bristol Myers Squibb (BMS) released its Global Position Statement on Human Rights in March 2025, outlining its commitment to upholding human rights throughout its operations and value chain. The statement emphasizes transparent governance, ethical business practices, robust labor rights, and responsible supply chain management to promote an inclusive and safe working environment.
+80
Business Practices and Ethical Responsibility
March 27
The document demonstrates strong business practices and ethical responsibility through comprehensive guidelines on human rights, including transparency in governance, commitments to anti-corruption, and adherence to international ethical standards. BMS’s clear policies and structured approach indicate a proactive commitment to ethical business conduct.
+75
Labor Relations and Human Rights Practices
March 27
BMS's statement includes detailed commitments on labor rights, emphasizing non-discrimination, fair labor practices, and safe working conditions. The emphasis on training, supply chain accountability, and adherence to international labor standards reflects a positive approach to human rights within the workforce.
- JAN012025
Bristol Myers Squibb highlights its commitment to safe working conditions, fair wages, and ethical work practices. The company emphasizes robust employee safety measures, comprehensive benefits, and inclusive policies that protect against forced and child labor, aligning with values that oppose exploitative practices linked to authoritarian regimes.
+80
Labor Relations and Human Rights Practices
March 27
The article outlines Bristol Myers Squibb's proactive stance on employee safety, fair wages, and ethical labor practices. Their commitment to an injury-free environment, support for employee development and inclusion, and clear policies against child and forced labor demonstrate practices that oppose labor exploitation and the worker suppression often seen under authoritarian regimes.
- JAN012025
Bristol Myers Squibb has published clear employee workplace policies that emphasize strict adherence to international labor laws, including the prohibition of child labor, forced labor, and support for freedom of association. These policies illustrate the company's commitment to ethical labor practices and a broader stance against authoritarian labor abuses.
+75
Labor Relations and Human Rights Practices
March 27
Bristol Myers Squibb's published employee workplace policies strongly emphasize compliance with global labor standards and ethical guidelines by refusing any association with practices that violate labor rights. This proactive stance against child labor, forced labor, and restrictions on freedom of association reflects a commitment to fair and just opportunities for employees, countering any potential complicity in authoritarian labor abuses.
- JAN102024
FEC records detail Bristol Myers Squibb's Political Action Committee filing, reflecting its engagement in political contributions and potential influence in politics. Such mechanisms consolidate corporate power, raising concerns about support for authoritarian policies and undermining democratic accountability.
-20
Political Contributions and Lobbying Efforts
March 27
Bristol Myers Squibb's operation of a Political Action Committee (BMS PAC), as evidenced by the FEC filing, underscores its active role in political financing. From an anti-fascist perspective, such contributions can be seen as a means to extend corporate influence in politics, potentially supporting candidates or policies that further authoritarian agendas. The use of a PAC for political contributions raises concerns regarding transparency and corporate complicity in undermining democratic accountability.
BRISTOL-MYERS SQUIBB COMPANY POLITICAL ACTION COMMITTEE (BMS PAC) - committee overview
- JAN012024
Bristol Myers Squibb issued a comprehensive human rights statement outlining its commitment to worker rights, robust human rights due diligence, and transparent reporting measures. The company emphasizes adherence to internationally recognized standards including the UN Guiding Principles on Business and Human Rights, supporting an inclusive workforce and safe working conditions.
+85
Labor Relations and Human Rights Practices
March 27
The event presents Bristol Myers Squibb's proactive commitment to labor rights and human rights as demonstrated in their detailed human rights position statement. Their policies on employee training, integrity reporting, and strict non-retaliation measures underscore an ethical approach to business practices that actively resists exploitative labor practices and reinforces democratic values.
- JAN012024
Bristol Myers Squibb has published a comprehensive human rights position statement detailing its commitment to protecting labor rights, ensuring product quality, and maintaining high ethical standards across its operations and supply chain.
+82.5
Business Practices and Ethical Responsibility
March 27
Bristol Myers Squibb’s human rights statement demonstrates a strong commitment to ethical business practices. The detailed policies on labor rights, employee safety, anti-discrimination, transparent reporting through the Integrity Line, and annual anti-trafficking statements collectively indicate an approach that actively safeguards human rights throughout its operations. This commitment under the umbrella of Business Practices and Ethical Responsibility is a positive sign against complicity in authoritarian practices.
- JAN012022
Bristol Myers Squibb spent $5.4 million on lobbying in 2022, raising concerns about the use of corporate funds to influence public policy and bolster authoritarian practices.
-50
Political Contributions and Lobbying Efforts
October 10
Bristol Myers Squibb's reported $5.4 million expenditure on lobbying in 2022 indicates a significant use of corporate resources to influence public policy. From an anti-fascist perspective, such activity raises concerns that the company is leveraging its financial power to support policies that undermine democratic accountability and may favor authoritarian practices.
- JAN062021
Bristol Myers Squibb publicly stated that it paused all political donations in the wake of the January 6, 2021 events, marking a stance against contributing to political funding that might support authoritarian agendas. The move reflects a commitment to ethical political behavior, a significant factor for those monitoring corporate support of democratic processes.
+80
Political Contributions and Lobbying Efforts
March 27
The decision by Bristol Myers Squibb to suspend all political donations following the events of January 6 is a positive indicator of their commitment to opposing extremist and potentially authoritarian political financing. This move aligns with the anti-fascist viewpoint that companies should refrain from engaging in financial practices that support authoritarianism.
- JAN012020
Bristol Myers Squibb actively partakes in political contributions by supporting state and local candidates and organizations. This activity, presented as a prudent engagement in the legislative process, raises concerns about corporate influence over public policy and potential alignment with authoritarian practices.
-40
Political Contributions and Lobbying Efforts
March 27
Bristol Myers Squibb’s political contributions, as detailed on their website, reveal a strategic effort to influence policy in ways that favor industry interests. While described as 'prudent contributions', this involvement in the political process raises concerns from an anti-fascist perspective about the potential erosion of democratic accountability and support for authoritarian-friendly policies. The association with industry groups and the clear involvement in funding political action committees may contribute indirectly to the rise of corporate-backed authoritarianism.
Alternatives
Darmstadt, Germany
12.29
Kenilworth, United States
2.89
Pasadena, United States
0.00
_0.png?VersionId=E54j6B2ssY0mos4wxJcXCOh7Hall1IAR)
New York, United States
-1.65
Cranbury, United States
-15.14
Cambridge, United States
-33.87
Indianapolis, United States
-35.34
Seattle, United States
-38.14
Menlo Park, United States
-49.80
Belgium (Ghent), Belgium
79.03
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 541711
- Research and Development in Biotechnology